BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Probiotic Mixture 2 {Vetafarm Probotic} - Faecalibacterium |
📓
Enterococcus faecium Modulates the Gut Microbiota of Broilers and Enhances Phosphorus Absorption and Utilization. Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 10 Issue 7 Pages: Pub: 2020 Jul 20 Epub: 2020 Jul 20 Authors Wang W , Cai H , Zhang A , Chen Z , Chang W , Liu G , Deng X , Bryden WL , Zheng A , Html Article Publication |
| Probiotic Mixture 2 {Vetafarm Probotic} - Faecalibacterium |
👶
Effects of probiotic Enterococcus faecium NCIMB 11181 administration on swine fecal microbiota diversity and composition using barcoded pyrosequencing Animal Feed Science and Technology (Animal Feed Science and Technology ) Vol: 201 Issue Pages: 80-88 Pub: 2015 Mar Epub: Authors Edward Alain B.Pajarillo , Dae-Kyung Kang , Chan-Soo Park , Hyeun Bum Kim , Marilen P Balolong , Publication Publication |
| Probiotic Mixture 2 {Vetafarm Probotic} - Faecalibacterium |
📓
The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice. Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 1054097 Pub: 2022 Epub: 2022 Dec 16 Authors Panattoni A , Calvigioni M , Benvenuti L , D`Antongiovanni V , Pellegrini C , Di Salvo C , Mazzantini D , Celandroni F , Fornai M , Antonioli L , Ghelardi E , Publication |
| Probiotic Mixture 2 {Vetafarm Probotic} - Faecalibacterium |
📓
Baseline gut microbial profiles are associated with the efficacy of Bacillus subtilis and Enterococcus faecium in IBS-D. Scandinavian journal of gastroenterology (Scand J Gastroenterol ) Vol: 58 Issue 4 Pages: 339-348 Pub: 2023 Apr Epub: 2022 Oct 25 Authors Hong G , Li Y , Yang M , Li G , Jin Y , Xiong H , Qian W , Hou X , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
